The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: A randomized, double-blind, placebo-controlled study

Acta Oto-Laryngologica

Volumn 126, Issue 6, 2006, Pages 606-612

  Stjärne, Pär ^a   Blomgren, Karin ^b   Cayé Thomasen, Per ^c   Salo, Sirkku ^d   Søderstrøm, Tor ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d Turun Korvacenter Oy   (Finland)

^e Allergologisk Poliklikk   (Norway)

Author keywords

Intranasal corticosteroid; Mometasone furoate; Nasal congestion; Nasal polyp; Olfaction; Quality of life; Rhinorrhea

Indexed keywords

MOMETASONE FUROATE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; FINLAND; HEADACHE; HUMAN; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; MALE; NORWAY; NOSE CONGESTION; NOSE POLYP; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCORING SYSTEM; SINGLE DRUG DOSE; SORE THROAT; SWEDEN; TREATMENT OUTCOME; TUMOR VOLUME; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INTRANASAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL OBSTRUCTION; NASAL POLYPS; PREGNADIENEDIOLS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33745727766     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480500452566     Document Type: Article

References (25)

1. Bachert C, Hormann K, Mosges R, Rasp G, Riechelmann H, Muller R, et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003;58:176-91.
2. Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:79-84.
3. Hamilos DL, Leung DY, Wood R, Bean DK, Song YL, Schotman E, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996; 15:443-50.
4. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
5. Bachert C, van Zele T, Gevaert P, De Schrijver L, Van Cauwenberge P. Superantigens and nasal polyps. Curr Allergy Asthma Rep 2003;3:523-31.
6. Mygind N, Lildholdt T. Medical management. In: Settipane GA, Lund V, editors. Nasal polyps: epidemiology, pathogenesis and treatment. Providence, RI: Oceanside Publications Inc; 1997. p. 147-55.
7. Blomqvist EH, Lundblad L, Anggard A, Haraldsson PO, Stjarne P. A randomised controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001; 107:224-8.
8. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975;5:159-64.
9. Deuschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977;15:17-23.
10. Ruhno J, Andersson B, Denburg J, Anderson M, Hitch D, Lapp P, et al. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis. J Allergy Clin Immunol 1990;86:946-53.
11. Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 1997;78:270-6.
12. Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998;124:513-8.
13. Jankowski R, Schrewelius C, Bonfils P, Saban Y, Gilain L, Prades JM, et al. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg 2001;127:447-52.
14. Filiaci F, Passali D, Puxeddu R, Schrewelius C. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology 2000;38: 185-90.
15. Berkowitz RB, Roberson S, Zora J, Capano D, Chen R, Lutz C, et al. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Allergy Asthma Proc 1999; 20:167-72.
16. Bronsky EA, Aaronson DW, Berkowitz RB, Chervinsky P, Graft D, Kaiser HB, et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:51-6.
17. Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther 1997;19:27-38; discussion 2-3.
18. Graft D, Aaronson D, Chervinsky P, Kaiser H, Melamed J, Pedinoff A, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996;98:724-31.
19. Small CB, Hernandez J, Reyes A, Schenkel E, Damiano A, Stryszak P, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol (in press).
20. Stjärne P. A randomized controlled trial of mometasone furoate nasal spray in nasal polyposis. Arch Otolaryngol Head Neck Surg (in press).
21. Rowe-Jones JM, Mackay IS. Management of nasal polyps. Curr Opin Otolaryngol Head Neck Surg 1998;6:41-6.
22. Bonfils P, Nores JM, Halimi P, Avan P. Corticosteroid treatment in nasal polyposis with a three-year follow-up period. Laryngoscope 2003;113:683-7.
23. Lund VJ, MacKay IS. Outcome assessment of endoscopic sinus surgery. J R Soc Med 1994;87:70-2.
24. Klimek L. Sense of smell in allergic rhinitis. Pneumologie 1998;52:196-202.
25. Saunders MW, Wheatley AH, George SJ, Lai T, Birchall MA. Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies. Laryngoscope 1999;109:785-90.